GlassScriptPhysician profile
Mark A Boissonneault
NPI 1508493248
$7,195.26
in general payments reported to CMS, 2019-2025
11 companies · $939 in 2025
The $939 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,704 · 2023: $714 · 2024: $1,838 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477 · Travel and Lodging: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.09 |
| Travel and Lodging | $1,014.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,912.56 | 2022-2025 | Prostep, Augment Injectable, Easyfuse |
| Liberty Surgical INC. | $1,257.93 | 2022 | |
| Arthrex, INC. | $1,127.63 | 2024 | |
| Treace Medical Concepts, INC. | $532.85 | 2024-2025 | |
| Smith+Nephew, INC. | $469.02 | 2023-2025 | Stravix, Grafix Pl, Oasis |
| Supreme Orthopedic Systems, LLC | $279.76 | 2023-2024 | |
| Amgen INC. | $224.80 | 2025 | Krystexxa |
| Triad Life Sciences INC. | $163.18 | 2022 | |
| Sanara Medtech INC. | $149.87 | 2024 | Celleraterx |
| Convatec INC. | $54.09 | 2023 | |
| Paragon 28, INC. | $23.57 | 2023 | Paratrooper |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Boissonneault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.